Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan in Hypertension and Coronary Artery Disease
NCT00274144Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Dec 2001
- Primary completion
- Mar 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of telmisartan in hypertension (HTN), coronary artery disease (CAD), sponsored by Boehringer Ingelheim. Started Dec 2001; status: completed.
02
Drugs
telmisartan
03
Conditions
hypertension (HTN)coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00274144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00274144.